NDC Package 85006-2908-1 Ahzantive

Aflibercept-mrbb Injection, Solution Intravitreal - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
85006-2908-1
Package Description:
.05 mL in 1 VIAL, SINGLE-DOSE
Product Code:
Proprietary Name:
Ahzantive
Non-Proprietary Name:
Aflibercept-mrbb
Substance Name:
Aflibercept-mrbb
Usage Information:
4. CONTRAINDICATIONS4.1 Ocular or Periocular InfectionsAHZANTIVE is contraindicated in patients with ocular or periocular infections.4.2 Active Intraocular InflammationAHZANTIVE is contraindicated in patients with active intraocular inflammation.4.3 HypersensitivityAHZANTIVE is contraindicated in patients with known hypersensitivity to aflibercept or any of the excipients in AHZANTIVE. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, severe anaphylactic/anaphylactoid reactions, or severe intraocular inflammation.
11-Digit NDC Billing Format:
85006290801
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Valorum Biologics, Llc
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Intravitreal - Administration within the vitreous body of the eye.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
BLA761378
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
06-01-2024
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 85006-2908-1?

The NDC Packaged Code 85006-2908-1 is assigned to a package of .05 ml in 1 vial, single-dose of Ahzantive, a human prescription drug labeled by Valorum Biologics, Llc. The product's dosage form is injection, solution and is administered via intravitreal form.

Is NDC 85006-2908 included in the NDC Directory?

Yes, Ahzantive with product code 85006-2908 is active and included in the NDC Directory. The product was first marketed by Valorum Biologics, Llc on June 01, 2024 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 85006-2908-1?

The 11-digit format is 85006290801. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-185006-2908-15-4-285006-2908-01